Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.
Press releases published on May 8, 2025
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
GlobeNewswire
·
May 8, 2025
– Ongoing clinical studies for four candidates on track with data expected in 2025, including interim Phase 1b data for long-acting helicase-primase inhibitors ABI-5366 and ABI-1179 anticipated in fall 2025 – – New data from multiple programs highlighted …
Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15
GlobeNewswire
·
May 8, 2025
DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system ( …
Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 …
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 8, 2025
DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …
4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
GlobeNewswire
·
May 8, 2025
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expected in Q3 2025, with topline data from both 4FRONT-1 and …
Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Regulatory Interactions and Commercial, Medical, and Corporate Preparations On-Track for Paltusotine New Drug Application with September 25, 2025 PDUFA Date CALM-CAH Phase 3 Study of Atumelnant for the Treatment of Adults with Congenital Adrenal …
Sprout Social Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its first quarter ended March …
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel in HLHS, a rare pediatric disease and orphan-designated indication, has reached approximately 95% enrollment and is expected to complete enrollment in the second quarter of 2025 …
Magnite to Participate in Upcoming Financial Conferences
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host in-person investor meetings at the following financial …
CarGurus Announces First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Marketplace revenue grew 13% YoY Q1'25 Net Income of $39.0 million; Non-GAAP Adjusted EBITDA of $66.3 million, up 32% YoY Repurchased $184.2 million worth of shares in Q1'25, representing 6% of our outstanding capital BOSTON, May 08, 2025 (GLOBE NEWSWIRE) …
Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025; Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025 Cash runway extending into the third quarter of 2026 with no debt Conference call …
Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical …
Varonis to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 8, 2025
MIAMI, May 08, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced its participation at the following upcoming conferences: The J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference …
Senseonics Holdings, Inc. Reports First Quarter Financial Results
GlobeNewswire
·
May 8, 2025
Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 …
EverCommerce Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
DENVER, May 08, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial …
Rumble Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
~ Revenue up 34% Year-over-Year to $23.7 Million ~ ~ Rumble Cloud Secures Contract with Government of El Salvador ~ ~ Significantly Improved MAU Retention Compared to 2022 Mid-Term Elections ~ ~ Tether Investment Completed, Balance Sheet Solidified ~ …
AvePoint Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
First quarter SaaS revenue of $68.9 million, representing 34% year-over-year growth, 37% on a constant currency basis First quarter Total revenue of $93.1 million, representing 25% year-over-year growth, 27% on a constant currency basis Total ARR of $345.5 …
Fulcrum Therapeutics to Participate in Upcoming May Conferences
GlobeNewswire
·
May 8, 2025
CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Cytek Biosciences Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
FREMONT, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first quarter ended March 31, 2025. First …
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 8, 2025
Presented positive 4- and 12-week clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, while continuing to function and persist with …